News-Medical.Net March 10, 2025
Versus Arthritis

A new 3D bio-printer that produces human-like tissue holds the potential to revolutionize the discovery of new drugs for cancer, heart disease and arthritis.

Scientists from Newcastle University, with funding from Versus Arthritis, have developed a unique approach to bioprinting cell-filled gels that can closely mimic human tissues, earning it a patent in the US and Europe.

While bioprinting has been around for several years, it has had multiple limitations that the team, led by Professor Kenny Dalgarno, has overcome. Such is the promise of the discovery, they have set up a spin out company, Jetbio, to attract investment to roll out the ReJI printer for use in labs across the world.

The groundbreaking process, called Reactive Jet Impingement (ReJI)...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: 3D Printing, Biotechnology, Pharma, Pharma / Biotech, Technology
The essential biotech news stories of the day
Healthcare & Life Sciences Private Equity Deal Tracker: Sycamore Partners to Acquire Walgreens
Sun Pharma buys Checkpoint and its new cancer drug
Beam launches $500m financing on base-editing trial data
Pharma Pulse 3/10/25: Streamlining Prescription Processes, Marty Makary Grilled at Senate Confirmation Hearing & more

Share This Article